Asterand, CompuCyte, GE Healthcare, Compugen, Novartis, Exigon, Thermo Electron, Schott Nexterion, Operon, Peter MacCallum Cancer Center, Agilent Technologies | GenomeWeb

Asterand, CompuCyte Team Up to Provide
Microarrays for Tissue Analysis Service

Asterand will include CompuCyte's quantitative cytometric analysis of tissues and tissue microarrays as a part of its current research molecular pathology services, the firms said last week.

The offering is an extension of Asterand's molecular pathology contract research service, which specializes in immunohistochemistry and RNA in situ hybridization studies using human tissue samples. The samples are assembled into tissue microarrays for expression analysis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.